3 Pharma Giants Battling for Immuno-Oncology Dominance
The run to see who can get out in front in the promising immuno-oncology field is a high stakes battle.
2 Small-Cap Biotechs for Your Watchlist
Omeros and Dynavax each have drugs that could produce huge gains. Risk of investment is also mitigated by certain factors in each company.
Can Anyone Dethrone Gilead?
Gilead is the clear leader in hepatitis C treatment. But other treatments appear to be solid and will produce successful results for investors.